Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial.
Dou K, Zhang D, Pan H, Guo N, Li L, Li Y, Zhang Q, Liu B, Shen Z, Zhang B, Liu J, Han W, Wang Y, Zhao Y, Yang Y, Chen S, Xie L, Guan C, Kirtane AJ, Xu B; CIT-RESOLVE Investigators.
Dou K, et al. Among authors: wang y.
JACC Cardiovasc Interv. 2020 May 11;13(9):1112-1122. doi: 10.1016/j.jcin.2020.01.233.
JACC Cardiovasc Interv. 2020.
PMID: 32381188
Free article.
Clinical Trial.